Research Article

Dynamics of Immune Checkpoints, Immune System, and BCG in the Treatment of Superficial Bladder Cancer

Figure 3

Model (5): despite the stimulation of effector cells by the BCG , the immune checkpoints block and deactivate the activities of the effector cells, thereby leading to the development and progression of cancer cells .